Logo NANOPILOT PROJECT

Objectives

NanoPilot will set-up a flexible and adaptable pilot plant operating under GMP for the production of small batches of polymer-based nanopharmaceuticals, which exhibit significant potential in the field of drug-delivery particularly for the design of second-generation nanopharmaceuticals.

The production of innovative nanopharmaceuticals in quantity and quality (GMP) required for them to enter clinical trials remains a challenge. Production cannot easily be implemented in existing manufacturing plants, specialized and optimized for the production of conventional drugs.

In addition, small companies usually do not have the resources to up-scale and implement GMP manufacturing of their potential nanopharmaceutical. This can limit the capacity of these organizations for advancing their research, and as a consequence, slow-down the development of innovative nanopharmaceuticals to treat different diseases.

In this context, it is urgently needed to provide those SMEs with the tools that can help them with the validation of their technologies.

 

OBJECTIVES BASED ON INDUSTRIAL NEEDS

  • Small GMP batches for clinical trials
  • Flexibility and adaptability
  • Regulatory compliance

SCIENTIFIC OBJECTIVES

  • Production of three nanopharmaceuticals
  • Integration of microfluidics
  • Highly advanced characterization techniques